2021: The Year of Real-World Data
The pandemic has specifically accelerated the pace of innovation in the realm of real-world data, fueling a number of trends that we expect will carry on and pick up steam post-COVID.
Bringing clarity
We are working to ensure that everyone touched by cancer has a clear path to the right care.
Our
We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.
Together, we can bring clarity to cancer care.
Providers
We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.
Payers
We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.
Life Sciences
Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
A Year in Review with Mike Doyle
In this year-end episode of Real World Talk, host Emily Di Capua talks to COTA President and CEO Mike Doyle.
Mike describes how COTA has helped the FDA in its quest to gather data on COVID-19, COTA’s increased data access, customer growth, and how they will continue to accelerate the use of RWD in 2021.
Latest
COTA Secures $34M in Growth Capital and Triples Data Access to Better Serve Life Science Partners and Provider Institutions
Access to Over One Million Patient Data Records and Additional Funding Support Enhanced Real-World Data and Analytics Services in Oncology
The Challenges of Value-Based Care and Why it’s Worth it with Barry Russo
In this episode of Real World Talk, Nick Ritter talks to Barry Russo, CEO of The Center for Cancer and Blood Disorders.
They discuss the benefits and challenges of value-based care (VBC), an approach that takes into account every aspect of a patient’s health instead of focusing on just one issue, like cancer.
Let’s work together to transform cancer care.
